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A B S T R A C T
Background: Hopelessness is a common experience of patients with depressive disorders (DD) and an important
predictor of suicidal behaviour. However, stability and factors explaining state and trait variation of hope-
lessness in patients with DD over time are poorly known.
Methods: Patients with DD (n=406) from the Vantaa Depression Study and the Vantaa Primary Care Depression
Study filled in the Beck Hopelessness Scale (BHS), Beck Depression Inventory (BDI), Beck Anxiety Inventory
(BAI), Perceived Social Support Scale–Revised (PSSS-R), and Eysenck Personality Inventory–Q (EPI-Q) at
baseline, at six and eighteen months, and at five years. We conducted a multilevel linear regression analyses
predicting BHS with these covariates.
Results: During the five-year follow-up half of the variance in BHS was attributable to between-patient variance
(50.6%, CI= 41.2–61.5%), and the rest arose from within-patient variance and measurement errors. BDI and
BAI explained 5.6% of within-patient and 28.4% of between-patient variance of BHS. High Neuroticism and low
Extraversion explained 2.6% of the between-patient variance of BHS. PSSS-R explained 5% of between-patient
variance and 1.7% of within-patient variance of BHS.
Limitations: No treatment effects were controlled.
Conclusions: Hopelessness varies markedly over time both within and between patients with depression; it is
both state- and trait-related. Concurrent depressive and anxiety symptoms and low social support explain both
state and trait variance, whereas high Neuroticism and low Extraversion explain only trait variance of hope-
lessness. These variations influence the utility of hopelessness as an indicator of suicide risk.
1. Introduction
Hopelessness – negative expectation of one's future – is a common
experience of patients with depressive disorders (Beck, 1963; Kendler,
2017). Hopelessness plays a central role in two main cognitive theories
of depression: Beck's original cognitive theory (Beck, 1963; Beck, 1964)
and the hopelessness theory of depression (Abramson et al., 1978). In
the original Beck's cognitive theory, hopelessness was a part of the
cognitive triad of depression: a negative belief about self, the en-
vironment, and the future; and an important risk factor of suicide (Beck,
1964; Kovacs and Beck, 1978). Specifically, Beck et al. (1990) postu-
lated that patients’ conceptualization of their situation as untenable
leads them to believe that suicide is the only feasible way of dealing
with apparently insoluble problems (Beck et al., 1990).
Abramson et al. (1978) defined hopelessness as a factor mediating the
relation between a stressful event and occurrence of hopelessness de-
pression (Liu et al., 2015). In the hopelessness theory, vulnerable
people tend to attribute negative life events to stable and global causes,
therefore perceiving that they are “flawed, unworthy, or deficient”,
which in turn predisposes to suicidal ideation (Abramson et al., 2000).
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Both theories have been empirically tested (see e.g. Beck et al., 1979;
Abramson et al., 2000 for reviews), partly overlap (Possel and
Thomas, 2011), and postulate hopelessness to represent a link between
depression and suicide.
Derived from Beck's original cognitive theory of depression, hope-
lessness is further identified as one of the central risk factors for suicide
in numerous epidemiological studies (Beck et al., 1990). However,
while it is one of the established risk factors for suicide deaths among
subjects with depression (Hawton et al., 2013), recent meta-analyses of
risk factors for suicide following self-harm (Chan et al., 2016) or sui-
cidal behaviour (Carter et al., 2017) have questioned the predictive
value of hopelessness (Ribeiro et al., 2018). There are multiple reasons
for poor predictive validity of measures in predicting suicidal acts, but
one neglected aspect is temporal variability. For any risk factor for
suicide, it is crucial to know the extent of which it is trait-related and
situationally specific (i.e. state-related) (Kraemer et al., 1997). A trait
factor may represent vulnerability for suicide and can be used to
identify patients at risk regardless of the time of the measurement. A
state factor, representing a disorder-related characteristic, is measur-
able only during the course of the disorder (Kraemer et al., 1994). Thus,
unlike with temporally stable, trait-like risk factors, timing of mea-
surement may be crucial for obtaining valid estimates of risk in case of
temporally variable, state-related risk factors. Consequently, it is
important to know the degree to which hopelessness represents trait- or
state-like characteristics among patients with depression.
To our knowledge, only one study on state and trait characteristics
of hopelessness in a clinical sample exists. Young et al. (1996) de-
monstrated that patients with depression had a baseline level of
hopelessness when not depressed, and an increment in hopelessness
attributable to both the severity of depression at the time and an in-
dividual-specific sensitivity to hopelessness in depression. The authors
postulated that baseline hopelessness and individual sensitivity to
hopelessness in depression represent trait components of hopelessness,
whereas the increment due to depression symptoms represents a state
component of hopelessness (Young et al., 1996).
Factors explaining the state and trait variation of hopelessness are
only partly known. In Beck's cognitive theory of depression (1963,
1986), hopelessness, emerging during depressive episodes, constitutes a
cognitive schema of a depressed person (Beck and Haigh, 2014).
However, Young et al. (1996) found that severity of depression only
partially explained state hopelessness, the intensity of which varied
from person to person at the same level of depression.
Personality traits may underlie trait hopelessness. In the framework
of the five-factor model of personality (Costa, 1991), high Neuroticism
is a general vulnerability factor for the development of internalizing
disorders, whereas low Extraversion relates more specifically to
Table 1
Methods used in the Vantaa Depression Study (VDS) and the Vantaa Primary Care Depression Study (PC-VDS).
Cohort VDS PC-VDS
Timing of screening 1 Feb 1997 to 31 May 1998 1 Jan 2002 to 31 Dec 2002
Catchment area City of Vantaa (population 169 000 in 1997) Two districts in the city of Vantaa (population 63 400
in 2002)
Setting Department of Psychiatry of the Peijas Medical Care District, Helsinki University
Central Hospital, Vantaa, Finland
Primary Health Care Organization of the City of
Vantaa, Finland
Three health centres
Two maternity clinics served by 30 general
practitioners with population-based responsibility
Target group All psychiatric patients aged 20–59 years Consecutive primary care patients aged 20–59 years in
general practitioners’ waiting room(1)
seeking treatment
(2)
referred to treatment, or
(3)
already in treatment with an acute deteriorating clinical state
Exclusion from screening ICD-10 schizophrenia, BD I Poor general health status prohibiting completion of
screening form
Screening procedure (1) Five screening questions for depression from SCAN, 1 positive, or
(2) Scale for Suicide Ideation, score≥ 6
(1) PRIME-MD: one positive mood disorders item,
and
(2) Telephone interview: one or more main
symptoms of depression according to SCID-I/P
Total screened 806 1111 (8 refused)
Screened positive 703 402
Refusals 161 (22.9%) 37 (9.2%)
Diagnostic interview After informed consent, DSM-IV (Axis I, SCAN) and DSM-III-R (SCID-II, modified to
DSM-IV)
After informed consent DSM-IV (SCID-I/P and SCID-II)
Inclusion criteria DSM-IV MDD with a new depressive episode DSM-IV depressive disorders
Cohort 269 (46 inpatients, 223 outpatients) 137 outpatients from primary care
Number of patients at 6-
month follow-up
229 (85.1%) –
Number of patients at 18-
month follow-up
198 (77.3%) 92 (67.2%)
5-year follow-up
Number of Patients 182 (67.7%) 112 (82.0%)
Switch of diagnosis 29 BD, 1 schizophrenia, 2 schizoaffective disorder 5 BD
Participants vs. non-
participants
More often female (72.1% vs. 55.6%, χ2= 6.581, p=0.010), married or cohabiting
(75.6% vs. 59.7%, χ2= 7.725, p=0.005), less alcohol dependence at baseline (39.5%
vs. 72.3%, χ2= 16.064, p<0.001)
No difference in age, gender, or baseline depression
severity
Mean time for interview 5.2 years 5.2 years
Diagnostic reliability at
baseline
20 videotaped diagnostic interviews; kappa coefficient for current MDD=0.86 (95%
CI= 0.58 to 1.00); not tested for comorbidity
20 videotaped diagnostic interviews; kappa coefficient
for current MDD=1.0; not tested for comorbidity
MDD=Major Depressive Disorder; PRIME-MD=Primary Care Evaluation of Mental Disorders; SCID-I/P= Structured Clinical Interview for DSM-IV Axis I
Disorders, research version, patient edition with psychotic screen; SCID-II= Structured Clinical Interview for DSM-IV Personality Disorders; WHO SCAN=World
Health Organization Schedules for Clinical Assessment in Neuropsychiatry, version 2.0
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depression (Clark et al., 1994). Young et al. (1996) found that only low
Extraversion, but not high Neuroticism, predicted trait hopelessness.
Another study showed that both high Neuroticism and low Extraversion
predicted hopelessness in a student sample (Chioqueta and
Stiles, 2005). Thus, the relationship between personality traits and trait
hopelessness remains to be clarified. Furthermore, Panzarella et al.
(2006) supposed that social support may reduce the cognitive vulner-
ability to depression by decreasing trait hopelessness. However, we are
not aware of any longitudinal study examining the role of social support
in state and trait variations of hopelessness among patients with de-
pressive disorders.
The aim of our observational study was to assess a) the degree to
which hopelessness, experienced by patients with depressive disorders
during a five-year follow up, represents a situational phenomenon
(state variance) as opposed to a stable cognitive vulnerability trait (trait
variance); and b) the extent that depression and anxiety symptoms,
Extraversion and Neuroticism, and social support explain state versus
trait hopelessness. We hypothesized that depressive and anxiety
symptoms are specifically associated with state variation of hope-
lessness, personality traits with trait variation of hopelessness, and so-
cial support with both state and trait variation of hopelessness.
2. Methods
2.1. Vantaa Depression Study (VDS) and Vantaa Primary Care Depression
Study (PC-VDS)
Patients came from two separate but comparable cohorts – VDS and
PC-VDS. Both are the collaborative research projects of the Mood
Disorder Research Unit of the Department of Mental Health and
Substance Use of the National Institute of Health and Welfare, Helsinki,
Finland. The pertinent ethics committee approved the research proto-
cols. The methodologies of the studies are presented in Table 1 and
have been described in more detail elsewhere – for VDS (Holma et al.,
2008; Melartin et al., 2002) and for PC-VDS (Riihimaki et al., 2014).
2.2. Patients
Altogether 1917 primary care or psychiatric patients were screened
for acute depressive states (PC-VDS) or major depressive disorder
(MDD) (VDS). Patients were fully informed about the study and gave
written informed consent. In PC-VDS, two-thirds of the patients had
MDD, and the rest had dysthymia, currently subsyndromal but lifetime
MDD, or true minor depression.
The final baseline dataset included 269 MDD patients (VDS) and
137 depressive disorder patients (PC-VDS) (total n= 406), sampled at
four occasions (comprising 1624 observations altogether).
Sociodemographic characteristics of the patients are shown in Table 2.
Our main aim was to test how different covariates affect the state-trait
decomposition of hopelessness, and therefore, we removed any possi-
bility of missing data (and imputation) -related confounding by ex-
cluding all records of patients with any missing values in any of the
covariates. This resulted in a data frame of 1099 observations.
However, a sensitivity analysis with (multilevel) imputed data using
“jomo” R package, version 2.6–2, did not indicate serious bias due to
missing values (see supplementary material, page 4 and Supplementary
Table 2).
3. Baseline and follow-up evaluation
3.1. Baseline assessment
Full DSM-IV axis I diagnoses (SCID-I/P in PC-VDS; SCAN in VDS)
and axis II diagnoses (SCID-II for DSM-IV in PC-VDS; SCID-II for DSM-
III-R in VDS) were made. Interrater agreement in diagnostic interviews
was excellent (kappa 0.86–1.00) (Melartin et al., 2002, Vuorilehto
et al., 2005).
3.2. Follow-up assessment
After baseline assessments, patients were interviewed at 6 (VDS)
and 18 months (VDS and PC-VDS) and at 5 years (VDS and PC-VDS).
3.3. Scales
We collected the following self-reported scales at both baseline and
all follow-up assessments: the Beck Hopelessness Scale, BHS
(Beck et al., 1974), the Perceived Social Support Scale –Revised, PSSS-R
(Blumenthal et al., 1987), the 21-item Beck Depression Inventory, BDI
(BECK et al, 1961), and the 21-item Beck Anxiety Inventory, BAI
(Beck et al., 1988). In addition, we administrated the 17-item Hamilton
Depression Scale, HAM-D (HAMILTON, 1960) at all-time points. Per-
sonality was assessed with Eysenck Personality Inventory –Q (EPI-Q), a
short measure based on EPI (Eysenck and Eysenck, 1964). EPI-Q com-
prises 18 items, 9 of the EPI's original 24 neuroticism items and 9 of the
original 24 extraversion items.
4. Statistical methods
We estimated linear mixed-effects (a.k.a. multilevel) models ("lme4″
package, version 1.1–12) using R software version 3.3.2 (Bates et al.,
2015). A mixed-effect model consists of both fixed and random effects.
A fixed-effect regression coefficient β refers to a usual regression coef-
ficient. A random-effect regression coefficient γj is an effect on the
outcome for an individual i (β+ γj)x, and it varies over individuals.
Only the variance of γis across individuals can be estimated and is de-
noted here by σγ. If x=1 for all individuals and time points, then γj is
also called the random intercept and captures the between-individual
variance in the outcome. The remaining error variance not captured by
any other fixed or random effect is the within-individual error variance,
σW, which includes everything left unexplained by the model covari-
ates.
The multilevel structure of our data derives from multiple assess-
ments of the same individuals. Thus, a linear mixed-effect model
equation may be written as
= + + + +y β β x γ x ζ ɛ ,i i j i i j i i0 1 [ ] [ ]
where yi represents one observation of the long-form data and j[i] in-
dexes repeated assessment of the same participant. The terms β0 and β1
refer to the fixed-effect regression coefficients, and εi is the residual
term. In addition, we have a random-effect intercept/residual ζj[i],
which is fixed within individual j, the subject of the observation, but
varies across individuals. Consequently, its variance captures the part of
the residual variance that is due to stable between-individual differ-
ences and is denoted here by σB. The remaining residual variance εi is
attributable to within-individual change and errors of measurement and
is denoted by σW.
Alternatively, σB and σW can be regarded as different types of re-
sidual variances. Addition of a time-varying fixed effect can reduce
either type of residual variation, or both. We were specifically inter-
ested in what type of residual variation certain fixed covariates reduce
or explain. The concept of coefficient of determination, or R2, is a
counterpart to residual variance, quantifying the proportion of variance
explained by fixed effects, rather than that left unexplained. Linear
mixed-effects models (LMM) can explain two types of variance
(Nakagawa and Schielzeth, 2013). In addition to marginal variance
explained (R2LMM(m)) by the fixed-effect covariates, there is also the
conditional variance explained (R2LMM(c)) when holding γij constant;
R2LMM(c) equivalently refers to all outcome variance explained by both
random and fixed effects. Fixed covariates that explain trait variance
increase the marginal R2LMM(m), but do not necessarily affect the
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Table 2
Sociodemographic characteristics, and mean scores and standard deviations (SD) of Scale for Suicidal Ideation (SSI), Beck Depression Inventory (BDI), Beck Anxiety
Disorder (BAI), Hamilton Rating Scale for Depression (HAM-D), Beck Hopelessness Scale (BHS) and Perceived Social Support Scale –Revised (PSSS-R) in Vantaa
Depression Study (VDS, n=269) and Vantaa Primary Care Depression Study (PC-VDS, n=137).
VDS (n=269) PC-VDS (n=137)
n % n % χ2 p
Gender ns
Female 197 73.2 104 75.9




92 34.3 44 34.4
Vocational 69 25.6 35 27.4




135 50.2 72 55
Single 134 49.8 59 45
Work statusc 39.903 <0.001
Employed 194 73.5 83 61.0
Unemployed 57 21.5 27 20.0




Any anxiety disorder 152 56.5 59 43.1 6.569 0.012
Alcohol dependence, 38 14.1 6 4.4 8.924 0.002
current
Any personality 118 43.9 71 51.8 ns
disorder, current
Mean SD Mean SD t p
Age, bl 39.7 11.1 45.3 13.7 −4.435 <0.001
BDI, bl 27.6 8.6 19.3 10.0 8.799 <0.001
BDI, 6 monthsi 12.7 10.0 15.0 11.4 −1.984 0.048
BDI, 18 monthsl 11.4 10.4 12.9 11.0 ns
BDI, 5 yearsm 10.7 10.5 14.4 11.2 −2.856 0.005
BAI, bld 22.4 10.6 17.0 12.6 4.485 <0.001
BAI, 6 monthsi 13.7 10.6
BAI, 18 monthsj 11.6 10.5 14.7 12.0 −2.464 0.014
BAI, 5 yearsk 13.1 10.8 13.6 12.5 ns
BHS, ble 10.3 4.8 8.8 5.3 2.859 0.004
BHS, 6 monthsf 7.9 5.2
BHS, 18 monthsg 7.4 5.2 7.6 5.8 ns
BHS, 5 yearsh 6.3 4.7 7.4 5.3 ns
HAM-D, bl 19.3 6.2 16.1 5.3 8.399 <0.001
HAM-D, 6 monthsi 9.2 7.7
HAM-D, 18 monthsj 8.3 7.4 9.8 6.9 ns
HAM-D, 5 yearsn 10.0 8.5 11.3 7.9 ns
PSSS-R, blo 39.1 12.8 43.0 12.6 −2.876 0.004
PSSS-R, 6 monthsi 42.6 12.6
PSSS-R, 18 monthsp 42.5 13.6 45.7 12.4 −1.986 0.048
PSSS-R, 5 yearsr 42.3 12.9 47.0 12.5 −2.995 0.003
a missing data 9/137,
b missing data 6/137,
c missing data 5/269,
d missing data 1/269, 4/137,
e missing data 1/269, 5/137,
f missing data 94/269,
g missing data 42/269, 35/137,
h missing data 112/269, 29/137,
i missing data 40/269,
j missing data 62/269,11/137,
k missing data 86/269, 27/137,
l missing data 63/269,
m missing data 80/269, 27/137,
n missing data 81/269, 26/137,
o missing data 1/269, 7/137,
p missing data 62/269, 35/137,
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conditional R2LMM(c) because it already includes the trait variance.
We compared models with and without different model components
using likelihood-ratio tests. Ninety-five percent likelihood-profile con-
fidence intervals (CIs) were presented for the individual model com-
ponents. We standardized the outcome variable to have unit variance
and zero mean in the long-data format (i.e., across all observations),
except for binary outcomes. Continuous exposure (i.e., 'independent')




Spearman's correlations between BHS and BDI (hopelessness item
excluded) total scores varied between 0.47 and 0.7 (p<0.001) at the
four time points (see Supplementary Table 1 and Supplementary
Figs. 1–4).
5.2. Baseline model for hopelessness
Half of the variance in hopelessness across all cohorts and follow-
ups was due to stable between-patient differences (50.6%,
CI= 41.2–61.5%), and the rest due to within-patient change and
measurement errors. There was a significant decreasing time trend in
hopelessness after the study baseline (βt1=−0.39, βt2=−0.42,
βt3=−0.53, with subscript tn denoting the nth follow-up after baseline)
(Table 3). We then assessed whether different covariates were asso-
ciated with between- and/or within-patient variance by comparing the
baseline model estimates with models that include a specific covariate
set.
5.3. Effects of depression and anxiety on hopelessness variance partition
Depressive symptoms had a highly significant fixed effect on
hopelessness, irrespective of whether assessed by BDI or HDS. However,
the random-effect slope of BDI was non-significant (χ2= 4.53, d.f. = 2,
p=0.104), as was that of HDS (χ2= 4.94, p=0.085), meaning that
individuals were not found to be heterogeneous in how their depressive
symptoms related to their hopelessness. The same held for anxiety
symptoms assessed by BAI (χ2= 0.298, p=0.862). Furthermore, when
all BDI, HDS, and BAI were included in the same model, the fixed effect
of HDS was no longer statistically significant (β=−0.054,
CI=−0.13–0.02). Table 3 shows how the baseline model changes
when including BDI and BAI in the model, whereas Fig. 1 illustrates
standard deviations of the between- and within-patient residuals across
the covariate conditions.
5.4. Effects of personality on hopelessness variance partition
Extraversion had a significant random-effect slope on hopelessness
(χ2= 6.49, d.f. = 2, p=0.039), whereas neuroticism did not reach
statistical significance: (χ2= 5.18, p=0.075). The random-effect slope
of extraversion reached statistical significance because of its strong
negative correlation with the random-effect intercept [r=−0.71,
CI= (−1, −0.17)]. In other words, the strength of the extraversion-to-
hopelessness association varied negatively with within-individual
(state) fluctuations in hopelessness, adding 0.11 s.d. units of between-
Table 3
Multilevel linear regression models predicting hopelessness.
Effect type Variable Model I Model II Model III Model IV
β CI low CI upp β CI low CI upp β CI low CI upp β CI low CI upp
Fixed Intercept 0.22 0.12 0.33 −0.170 −0.270 −0.08 −0.139 −0.231 −0.047 −0.097 −0.186 −0.007
Sex (male) 0.32 0.13 0.50 0.300 0.160 0.44 0.247 0.110 0.385 0.151 0.018 0.284
Follow-up 1 −0.38 −0.51 −0.24 0.220 0.094 0.36 0.193 0.062 0.324 0.162 0.034 0.290
Follow-up 2 −0.41 −0.52 −0.31 0.200 0.089 0.31 0.178 0.069 0.289 0.153 0.046 0.261
Follow-up 3 −0.54 −0.66 −0.43 0.068 −0.047 0.18 0.029 −0.087 0.146 0.005 −0.108 0.120
BDI – – – 0.480 0.410 0.54 0.435 0.366 0.506 0.385 0.316 0.454
BAI – – – 0.150 0.085 0.21 0.118 0.056 0.181 0.103 0.042 0.164
Extraversion – – – – – – −0.113 −0.166 −0.060 −0.079 −0.131 −0.027
Neuroticism – – – – – – 0.064 0.008 0.121 0.049 −0.006 0.104
Social support – – – – – – – – – −0.218 −0.272 −0.164
σ CI low CI upp σ CI low CI upp σ CI low CI upp σ CI low CI upp
Random Between 0.490 0.400 0.590 0.243 0.1900 0.3000 0.223 0.170 0.279 0.195 0.147 0.245
Within 0.445 0.400 0.490 0.361 0.3200 0.4000 0.360 0.322 0.398 0.349 0.312 0.385
R2 R2 R2 R2
R2LMM Marginal 0.070 – – 0.354 – – 0.380 – – 0.430 – –
Conditional 0.558 – – 0.614 – – 0.617 – – 0.634 – –
ΔR2 ΔR2 ΔR2
ΔR2LMM Marginal – – – 0.284 – – 0.310 – – 0.360 – –
Conditional – – – 0.056 – – 0.059 – – 0.076 – –
Note: Values in the table are regression coefficients (β) and variance-component estimates (σ), their lower (low) and higher (upp) 95% confidence intervals (CI, “low”
for lower, “upp” for upper), and explained variance proportions (R2) and changes in explained variance from a preceding model to model at the indicated column
(ΔR2). Model I is the baseline model, Model II adds depression (BDI) and anxiety (BAI) covariates, Model III further adds personality covariates, and Model IV adds a
covariate for perceived social support.
Fig. 1. Standard deviances (s.d.) of the residuals of the linear mixed regression
model explaining variance of hopelessness. Whiskers represent 95% likelihood-
based confidence intervals, the dashed line the baseline between-patient re-
sidual standard deviance, and the dotted line the baseline within-patient re-
sidual standard deviance.
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individual variance to the estimated fixed-effect, i.e., to β=−0.259,
CI= (−0.32, −0.20). The random-effect slope was not only con-
founded with intercept but also had a negligible effect on explained
variance, however, and was therefore omitted from further models for
simplicity. The fixed-effect regression of hopelessness on neuroticism
was estimated at β=0.311, CI= (0.26, 0.37). As expected, the per-
sonality covariates alone explained a portion of between-patient var-
iation in the data, but little within-patient variation (Fig. 1). Adjusting
for depression and anxiety attenuated effects of personality traits, but
they remain significant contributors to the model (Table 3).
5.5. Effects of perceived social support on hopelessness variance partition
Perceived social support had a nearly significant random-effect
slope on hopelessness (χ2= 5.67, d.f. = 2, p=0.059), but this “near
hit” vanished after constraining its near perfect negative correlation
(confounding) with the random intercept to zero (χ2= 0.30, d.f. = 1,
p=0.584). We excluded the random slope from the model, but the
fixed effect of perceived social support [β=−0.407, CI= (−0.46,
−0.35)] was a statistically significant explanation for the between-
patient variance in hopelessness (Fig. 1). Furthermore, it significantly
added to the model including depression, anxiety, and extraversion and
neuroticism personality traits (χ2= 60.02, d.f. = 1, p<0.001;
Table 3).
6. Discussion
In this observational five-year prospective study on 406 patients
with depressive disorders, we found that patients with depressive dis-
orders demonstrate both depression-related hopelessness and stable,
trait-like hopelessness to an equal quantitative degree. Symptoms of
depression and anxiety were substantial covariates of both state and
trait variance of hopelessness. Personality traits of Neuroticism and
Extraversion both partially underlie a trait component of hopelessness.
Finally, perceived social support significantly predicted hopelessness,
explaining both state and trait variation of hopelessness.
This study has several strengths. First, to our knowledge, this is the
first study reporting the quantitative degree of state and trait variance
of hopelessness in patients with depressive disorder during a five-year
follow-up. Second, our study is the first to investigate the predictive
value of symptoms of depression and anxiety, personality traits, and
social support in state and trait variation of hopelessness. Third, we
used the mixed-effects linear regression analysis, which allowed as to
estimate both within- and between-patient differences in hopelessness.
Fourth, we gathered extensive data on self-reported symptoms of de-
pression and anxiety as well as Neuroticism and Extraversion and
perceived social support at four time points. This allowed us to evaluate
the extent to which these covariates affect self-reported hopelessness in
a dynamic manner. Fifth, the two cohorts cover a relatively large and
regionally representative number of patients with depressive disorders,
and both the cohorts employed similar methodologies, allowing their
valid comparisons and pooling of data. Sixth, we assessed the depres-
sion symptoms using both the self-reported BDI and HAM-D, adminis-
tered by a health care professional. This allowed us to rule out some of
the potential bias related to self-report. Seventh, we verified the clinical
diagnoses in structured clinical diagnostic interviews. Seventh, we
conducted the sensitivity analysis with and without the imputation
method. No significant bias related to missing values emerged.
Nevertheless, the study also has limitations. First, individual-spe-
cific treatment effects were not controlled, although an average trend of
recovery was taken into account. Specific treatments received by the
patients could have differentially influenced the degree of hopelessness
by reducing severity of symptoms of depression and anxiety. Second,
the patients repeatedly filled in the self-report questionnaires during
mood-disorder episodes, which could have been affected by impair-
ments in social cognition (Hoertnagl and Hofer, 2014),
autobiographical memory disruptions (Talarowska et al., 2016), and
distortions in self-reflection (Philippi and Koenigs, 2014). However,
these self-report tools are widely used in clinical settings despite their
potential limitations. Third, personality was assessed with the Eysenck
Personality Inventory, as more modern scales such as the NEO Five-
Factor Inventory (Costa and McCrae, 1992) were not available in Fin-
nish at the time that the follow-up study commenced. However, the
correlation of neuroticism and extraversion dimensions between EPI
and NEO has been found to be high (r=0.77 for both dimensions)
(Aluja et al., 2002). Fifth, we measured hopelessness in patients who
already had a depressive disorder. Hence, we were unable to conclude
whether trait hopelessness represents a characteristic existing before a
first depressive episode, as Abramson et al (1989) suggested, or a
“scars” phenomenon (Zeiss and Lewinsohn, 1988).
We showed that patients with depressive disorder demonstrate both
state and trait characteristics of hopelessness during the five-year
follow-up. More specifically, half of the variance in hopelessness was
attributable to trait and half to state components of hopelessness.
Depressive symptoms affected both components. Young et al. (1996)
demonstrated similar substantial stability and variability of hope-
lessness in patients with depressive disorder. The same is also true for
bipolar disorder (Valtonen et al., 2009). Thus, among patients with
depressive disorders, hopelessness appears to comprise partly an en-
during experience, partly a negative view of the future, waxing and
waning in tandem with depressive mood.
Depression and anxiety symptoms explained 5.6% of the within-
patient variation in hopelessness. This is consistent with Beck's cogni-
tive theory, assuming that hopelessness may be an indicator of the se-
verity of depression (Beck, 1963). Moreover, in line with the findings of
Young et al. (1996), we showed that some depressed patients seem to
experience more hopelessness than others, even at the same degree of
depressive sympt0ms. Thus, the degree of hopelessness tends to in-
crease during a depressive episode and decrease in remission. For in-
stance, for 56 persons recovered from depression at 6 months, the de-
gree of hopelessness measured by BHS significantly decreased from 8.5
to 5.3 (data available on request), even though it did not disappear.
Consequently, in terms of suicide, the predictive value of hopelessness
measured when an individual is not depressed is probably lower than
when an individual is depressed. This notable temporal variability of
hopelessness should be taken into account when assessing its predictive
value. In addition, it is important to note that not all depressed patients
are equally hopeless. As our Supplementary Figures demonstrate, it is
quite possible to be clinically depressed without being significantly
hopeless, or vice versa.
Young et al. (1996) showed that more extensive trait hopelessness
was associated with several negative outcomes, including the more
frequent occurrences of depression and suicide attempts. In our study,
symptoms of depression and anxiety explained 28.4% of trait variance
of hopelessness, indicating that patients with more extensive trait
hopelessness tend to experience more depression and anxiety symp-
toms, and vice versa.
Patients with depressive disorders tend to demonstrate hopelessness
even when not depressed. High Neuroticism and low Extraversion were
statistically significant predictors of hopelessness, explaining 2.6% of
the between-patient variance of hopelessness. This finding is consistent
with the studies of Chioqueta et al. (2005) and Bayrami et al. (2012) on
student samples. High Neuroticism and low Extraversion are also as-
sociated with more severe depression and anxiety symptoms (Xia, et al.,
2011) and more time spent depressed. Therefore, high Neuroticism and
low Extraversion may partially underlie the trait component of hope-
lessness, which is, in turn, associated with more severe internalizing
pathology.
Finally, social support explained 5% of variance of trait hope-
lessness and 1.7% of state hopelessness. This finding is in line with the
expanded hopelessness theory of depression (Panzarella et al., 2006),
which postulates that adaptive inferential feedback, a subtype of social
I. Baryshnikov et al. Journal of Affective Disorders 239 (2018) 107–114
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support, might reduce trait hopelessness by decreasing negative in-
ferential styles and the likelihood of making maladaptive inferences
about negative life events. As low social support is a well-acknowledged
risk factor of suicidal behaviour (O'Connor and Nock, 2014), the degree
of hopelessness may play a mediational role between them.
Overall, the patients with depressive disorders show a notable
temporal variability of the degree of hopelessness, which aggravates
during depression and weakens after recovery. This temporal instability
is an essential consideration when assessing the association between
experienced hopelessness and risk for suicide. In addition, as state
hopelessness is markedly influenced by symptoms of depression and
anxiety, their effective treatment may alleviate the degree of hope-
lessness and risk of suicidal acts. Further studies on the association
between perceived social support, hopelessness and risk of suicide are
needed.
7. Conclusions
In the five-year follow-up, patients with depressive disorders de-
monstrated an enduring experience of hopelessness, the intensity of
which varied within and between patients. The degree of hopelessness
tends to escalate during depression and weaken after recovery, even
though it does not disappear. Furthermore, not all depressed patients
are equally hopeless. Symptoms of depression and anxiety substantially
explain both trait and state hopelessness. Trait hopelessness is partially
attributable to personality traits such as high Neuroticism and low
Extraversion. In addition, social support explains both state and trait
variance of hopelessness. The marked temporal variability of hope-
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